JTCS Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Mark K. Ferguson
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ferguson, M. K.
Right arrow Articles by Karrison, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ferguson, M. K.
Right arrow Articles by Karrison, T.

J Thorac Cardiovasc Surg 2000;119:440-448
© 2000 Mosby, Inc.


GENERAL THORACIC SURGERY

DOES PNEUMONECTOMY FOR LUNG CANCER ADVERSELY INFLUENCE LONG-TERM SURVIVAL?

Mark K. Ferguson, MD, Theodore Karrison, PhD

From the Departments of Surgery and Health Studies, The University of Chicago, Chicago, Ill.

Address for reprints: Mark K. Ferguson, MD, Section of Cardiac and Thoracic Surgery, The University of Chicago, 5841 S Maryland Ave, MC5035, Chicago, IL 60637 (E-mail: mferguso{at}surgery.bsd.uchicago.edu ).

Objective: The increased operative mortality associated with pneumonectomy has stimulated the use of lung-sparing operations such as sleeve lobectomy. Whether pneumonectomy adversely affects long-term outcome after lung resection is unknown.
Methods: We reviewed the cases of patients who underwent lobectomy/bilobectomy or pneumonectomy because of non–small cell lung cancer between January 1980 and June 1998. Survival curves were compared by the log-rank test. Covariates were determined for operative mortality and survival using logistic regression analysis and Cox proportional hazards estimation, respectively.
Results: There were 259 men and 183 women who underwent lobectomy/bilobectomy (340) or pneumonectomy (102). Operative mortality was 36 (8.1%) patients overall, 24 (7.0%) for lobectomy/bilobectomy and 12 (12%) for pneumonectomy. Mean follow-up was 41 months (range 0-222 months). Median survival was worse for pneumonectomy (stage II: 17.9 vs 36.3 months, log-rank P = .05; stage III: 11.7 vs 21.3 months, log-rank P = .07). However, important covariates for survival were age, primary tumor status, regional nodal status, and forced expiratory volume in 1 second. After adjusting for these covariates, survival did not differ significantly between the types of operations (hazard ratio for pneumonectomy 1.21; 95% CI 0.88-1.68).
Conclusions: We did not detect a significant long-term adverse influence of pneumonectomy on survival after adjusting for other prognostic factors, but randomized clinical trials would be needed to definitively address this issue.




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
C. Simon, N. Moreno, R. Penalver, G. Gonzalez, E. Alvarez-Fernandez, F. Gonzalez-Aragoneses, and Bronchogenic Carcinoma Cooperative Group of the Sp
The Side of Pneumonectomy Influences Long-Term Survival in Stage I and II Non-Small Cell Lung Cancer
Ann. Thorac. Surg., September 1, 2007; 84(3): 952 - 958.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
Z. Ma, A. Dong, J. Fan, and H. Cheng
Does sleeve lobectomy concomitant with or without pulmonary artery reconstruction (double sleeve) have favorable results for non-small cell lung cancer compared with pneumonectomy? A meta-analysis
Eur. J. Cardiothorac. Surg., July 1, 2007; 32(1): 20 - 28.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. J. Kim, J. G. Lee, C. Y. Lee, I.-k. Park, and K. Y. Chung
Long-term Survival Following Pneumonectomy for Non-Small Cell Lung Cancer: Clinical Implications for Follow-up Care
Chest, July 1, 2007; 132(1): 178 - 184.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
B. Yildizeli, E. Fadel, S. Mussot, D. Fabre, O. Chataigner, and P. G. Dartevelle
Morbidity, mortality, and long-term survival after sleeve lobectomy for non-small cell lung cancer
Eur. J. Cardiothorac. Surg., January 1, 2007; 31(1): 95 - 102.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
J. Lemaitre, Z. Mansour, E. A. Kochetkova, C. Koriche, X. Ducrocq, J.-M. Wihlm, E. Quoix, and G. Massard
Bronchoplastic lobectomy: do early results depend on the underlying pathology? A comparison between typical carcinoids and primary lung cancer.
Eur. J. Cardiothorac. Surg., July 1, 2006; 30(1): 168 - 171.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
S.-i. Takeda, H. Maeda, M. Koma, Y. Matsubara, N. Sawabata, M. Inoue, T. Tokunaga, and M. Ohta
Comparison of surgical results after pneumonectomy and sleeve lobectomy for non-small cell lung cancer.: Trends over time and 20-year institutional experience
Eur. J. Cardiothorac. Surg., March 1, 2006; 29(3): 276 - 280.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J.-F. Regnard, C. Perrotin, R. Giovannetti, O. Schussler, A. Petino, L. Spaggiari, M. Alifano, and P. Magdeleinat
Resection for Tumors With Carinal Involvement: Technical Aspects, Results, and Prognostic Factors
Ann. Thorac. Surg., November 1, 2005; 80(5): 1841 - 1846.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
Y. T. Kim, C. H. Kang, S. W. Sung, and J. H. Kim
Local Control of Disease Related to Lymph Node Involvement in Non-Small Cell Lung Cancer After Sleeve Lobectomy Compared With Pneumonectomy
Ann. Thorac. Surg., April 1, 2005; 79(4): 1153 - 1161.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. Aguilo and J. Minguella
Short- and Long-Term Mortality After Pulmonary Resection
Ann. Thorac. Surg., January 1, 2005; 79(1): 385 - 386.
[Full Text] [PDF]


Home page
JAMAHome page
J. D. Patel, P. B. Bach, and M. G. Kris
Lung Cancer in US Women: A Contemporary Epidemic
JAMA, April 14, 2004; 291(14): 1763 - 1768.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. K. Ferguson and A. G. Lehman
Sleeve lobectomy or pneumonectomy: optimal management strategy using decision analysis techniques
Ann. Thorac. Surg., December 1, 2003; 76(6): 1782 - 1788.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. Alexiou, D. Beggs, P. Onyeaka, K. Kotidis, S. Ghosh, L. Beggs, D. N. Hopkinson, J. P. Duffy, W. E. Morgan, and G. Rocco
Pneumonectomy for Stage I (T1N0 and T2N0) nonsmall cell lung cancer has potent, adverse impact on survival
Ann. Thorac. Surg., October 1, 2003; 76(4): 1023 - 1028.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
G. Varela, M. F. Jimenez, N. Novoa, and P. Macri
Discordance between predicted postoperative forced expiratory volumes in one second (ppoFEV1) calculated before and after resection of bronchogenic carcinoma
Interactive CardioVascular and Thoracic Surgery, June 1, 2003; 2(2): 138 - 142.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
M. K. Ferguson and A. E. Durkin
A comparison of three scoring systems for predicting complications after major lung resection
Eur. J. Cardiothorac. Surg., January 1, 2003; 23(1): 35 - 42.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
E. Fadel, B. Yildizeli, A. R. Chapelier, I. Dicenta, S. Mussot, and P. G. Dartevelle
Sleeve lobectomy for bronchogenic cancers: factors affecting survival
Ann. Thorac. Surg., September 1, 2002; 74(3): 851 - 859.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
A. Terzi, A. Lonardoni, G. Falezza, G. Furlan, P. Scanagatta, F. Pasini, and F. Calabro
Sleeve lobectomy for non-small cell lung cancer and carcinoids: results in 160 cases
Eur. J. Cardiothorac. Surg., May 1, 2002; 21(5): 888 - 893.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. Martin, R. J. Ginsberg, E. S. Venkatraman, M. S. Bains, R. J. Downey, R. J. Korst, M. G. Kris, and V. W. Rusch
Long-Term Results of Combined-Modality Therapy in Resectable Non-Small-Cell Lung Cancer
J. Clin. Oncol., April 15, 2002; 20(8): 1989 - 1995.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
P. Thomas, C. Doddoli, X. Thirion, O. Ghez, M.-J. Payan-Defais, R. Giudicelli, and P. Fuentes
Stage I non-small cell lung cancer: a pragmatic approach to prognosis after complete resection
Ann. Thorac. Surg., April 1, 2002; 73(4): 1065 - 1070.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. R. Handy Jr, A. I. Child, G. L. Grunkemeier, P. Fowler, J. W. Asaph, E. C. Douville, A. C. Tsen, and G. Y. Ott
Hospital readmission after pulmonary resection: prevalence, patterns, and predisposing characteristics
Ann. Thorac. Surg., December 1, 2001; 72(6): 1855 - 1860.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. Machtay, J. H. Lee, J. B. Shrager, L. R. Kaiser, and E. Glatstein
Risk of Death From Intercurrent Disease Is Not Excessively Increased by Modern Postoperative Radiotherapy for High-Risk Resected Non-Small-Cell Lung Carcinoma
J. Clin. Oncol., October 1, 2001; 19(19): 3912 - 3917.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2000 by The American Association for Thoracic Surgery.